The enzyme, 
Introduction
Glucose-6-phosphate dehydrogenase (G6PD) is essential to maintain stability of red blood cells (1) . It catalyzes the first step in the hexose monophosphate pathway of glucose metabolism and produces reduced nicotinamide adenine dinucleotide phosphate (NADPH) which is required for the maintenance of reduced glutathione (GSH). GSH is essential for protecting red cells from the oxidative damage. In G6PD deficiency the cells other than RBC do not have significant effect.
The inherited deficiency of this enzyme may manifest as congenital non spherocytic hemolytic anemia (CNSHA), drug induced hemolytic anemia (DIHA) or hemolytic disease of newborn. Deficiency of G6PD is the most common metabolic disorder of RBCs and has been estimated to affect over 400 million people worldwide (2) . Although global in its distribution, G6PD deficiency is encountered with greatest frequency in the tropical and subtropical zones of the eastern hemisphere. In some populations, more than 20 percent of the population may be affected by this enzyme deficiency (3) . In India, G6PD deficiency was first reported in 1961 by Baxi et al (4) and the prevalence rate varied from 0 -27% in different caste, ethnic and linguistic groups (5) . Neonatal jaundice is the most common clinical manifestation of G6PD deficiency (6) . It has been reported that one third of children with G6PD deficiency develop neonatal jaundice. Severe neonatal jaundice if untreated could give rise to kernicterus, a well known cause of death (7) and neurodevelopmental handicap. Jaundice can occur in neonates with G6PD deficiency due to spontaneous hemolysis or hemolysis following exposure to certain oxidant drugs and infection or due to reduced glucuronidation of bilirubin in the hepatocytes. It occurs primarily in Asian and Mediterranean infants (7) . In India, several groups of investigators have reported neonatal jaundice due to G6PD deficiency (8) The objectives of our study were: 1. To determine the frequency of G6PD deficiency in neonates admitted with clinically evident jaundice. 2. To study the effect of G6PD deficiency on the outcome of treatment of neonatal jaundice.
II. Materials and method
The study was conducted in the Special Care Neonatal Unit of Bankura Sammilani Medical College during the period from November 2010 to December 2011. All term and preterm babies upto seventh day of age admitted with clinically evident jaundice were taken for study. 
Principle
Glucose-6-Phosphate-Dehydrogenase (G6PD) present in hemolysate acts on substrates, Glucose-6-Phosphate(G6PO4) & NADP, giving NADPH which in presence of (polymethyl sulphate) PMS decolorizes blue colored indophenols dye (DCPIP) leaving behind color only due to hemolysate. The rate of reaction being proportional to enzyme activity (G6PD) present, time required for decolorisation is inversely proportional to enzyme activity in the hemolysate.
Sample Collection
Whole blood has been collected using EDTA as an anticoagulant.
Preparation of working Reagent
0.5 ml of G6PD-2(Buffer) is added to the vial labeled G6PD-1(Co-enzyme substrate). Shaked well to allow complete dissolution & used immediately.
Reagent storage & stability
All reagents have been stored at 2-8 0 C . G6PD-1 has been reconstituted just before use.
Procedure
Hemoglobin content of whole blood is estimated first. If the hemoglobin content is significantly less than 15 gm/dl, Hb content has been adjusted to 15 gm/dl by proportionately increasing the aliquot of whole blood during preparation of red cell.
Preparation of Red Cell Hemolysate:
Given below is a table showing quantity of blood required for 1 ml lysing reagent corresponding to the Hemoglobin content of blood(in gram/dl). Table: 1 Hemoglobin concentration ( in gram/dl)
Amount of blood to be taken (in ml) 7.0-9.5 0.04 9.6-11.5 0.03 11.6-13. 
Observation
First observation at 30 minute for decolorisation. If the decolorisation is incomplete, observation is done for every 5 minute, thereafter until the decolorisation is complete. In case, decolorisation takes longer than 60 min, the interval of observation is increased & followed up for 4-8 hours or more. In G6PD deficiency the time taken for decolorisation exceed from 2 hours to 24 hours.
Interpretation
1. In normal subjects, decolorisation time is between 30-60 min. 2. In G6PD deficient subjects, (heterozygous males & homozygous females) decolorisation time is between 2 to 24 hours.
Method employed for G6PD estimation
For the G6PD assay, 1 ml of anticoagulated blood in a glass bottle was sent and analyzed in the laboratory within two hours. Determination of the activity of G6PD was done by spectrophotometry. When low G6PD levels were encountered, the test was repeated on a fresh sample to confirm the deficiency of the enzyme. This test has been repeated 3 months later also when blood picture was suggestive of acute hemolysis.
III.
Results and analysis 
Overall Frequency
Twenty four newborns (13.63%; n=176) were found to have deficiency of G6PD enzyme. Out of those deficient, 20 (16.94% n=118) were males and 4 (6.89% n=58) were females. So, frequency was higher among male babies(Refer to table-2 ) Racial distribution of G6PD Deficiency:
Among 150 Non-tribal newborn babies, 18(12.00%; n=150) were G6PD deficient. Out of 26 Tribal newborn babies , 6 (23.07%%; n=26) were G6PD deficient.
We infer that there was strong evidence of significant difference between frequency of G6PD deficiency in Tribal and non-tribal group of newborns with more frequency of G6PD deficiency in tribal newborns with neonatal hyperbilirubinemia. Prevalence ratios among Non-tribal and Tribal neonates were 12.00% (18 deficient out of 150) and 23.07% (6 deficient out of 26) respectively. This difference is statistically significant (χ2 = 2.31; df=1 p <0.05 ). (Ref. to table: -2 )
Distribution of G6PD deficient babies according to Birth weight.
138 newborns (78.40%; n=176) had birth weight of 2500 gm or more and 38 (21.60% n=176) were less than 2500 gm. Among those with birth weight >/=2500 gm., 19 babies (13.76%; n=138) had G6PD deficiency.
Out of 38 neonates with birth weight <2500 gm. 5 babies (13.16%; n=38) were found to have this enzyme deficiency.
Frequency of the enzyme deficiency among babies this two group was similar as because the difference between the two ratios was not statistically significant (χ2 = 0.01 ; df= 1, p >0.05 ).
Distribution of cases according to gestational age:
One hundred & forty newborns (79.54%; n=176) in this study were term (GA >37wk) and 36 (20.46%) were preterm(GA <37wk). Nineteen(13.57%n=140) term & 5 preterm babies were G6PDdeficient. This difference in frequency of G6PD deficiency among term and preterm babies was not statistically significant (χ2 = 0; df=1. p >0.05) Study of Glucose -6-Phosphate Dehydrogenase deficiency in Neonatal Jaundice. Therefore, it can be said that most of the G6PD deficient babies had presentation of jaundice in between 2 nd to 4 th day.
Peak Serum Bilirubin
Of the 24 G6PD deficient babies, 8(33.33%, n=24) had a peak serum bilirubin level of less than 20 mg/dl. Five (20.83%; n=24) of the total deficient cases had a peak bilirubin level in the range of 20.1 to 25 mg/dl, 7(29.16%) babies had peak levels in the range of 25.1 to 30 mg/dl & 4(16.66%) had a peak serum bilirubin level more than 30 mg/dl. (Table- On the other hand, among 152 G6PD normal babies 124(81.57% n=152) had serum bilirubin level in the range of 12.1 to 20 mg/dl, 16(10.52% n=152) in between 20.1 to 25 mg/dl, 9(5.92% n=152) in the range of 25.1 to 30 mg/dl & 3(1.97% n=152) had >30 mg/dl. Mean peak serum bilirubin level in G6PD deficient & G6PD normal baby was 25.03 mg/dl & 18.03 mg/dl respectively ( Table:-4) .
Therefore, it is seen that in G6PD deficient babies, 12(50%n=24) had serum bilirubin level in the range of 20 to 30 mg/dl. On the other hand in G6PD normal group 124(81.57%n=152) had bilirubin level <20 mg/dl.
Duration of Phototherapy
All the 24 neonates with G6PD deficiency required phototherapy for a duration of more than 24 hours. Two babies(8.33%n=24) required phototherapy for a period of 24 to 48 hours. Eight (33.33%) needed phototherapy for 48 to 72 hrs. Ten (41.66%) required phototherapy for a period of 72 to 96 hrs. Only four babies required phototherapy for more than 96 hrs.
On contrary, among 152 G6PD normal babies, two (1.31% n=152) required phototherapy for less than 24 hrs, 58(38.15%) required phototherapy for 24-48 hrs, 60(39.47%) required 48-72 hrs of phototherapy, 25 required (16.44%) 72-96 hrs of phototherapy & only one baby was under phototherapy for more than 120 hrs duration. The mean duration of phototherapy of G6PD deficient & G6PD normal babies was 86(±18.17) hours & 62(±18.32) hours respectively.So, it is clear that in G6PD deficient babies 18(75%) needed phototherapy for 48 to 96 hours & in G6PD normal babies 118(77%) required phototherapy for 24 to 72 hours.
Requirement of Exchange Transfusion
Among 176 babies presented with early neonatal jaundice 23 required double volume exchange transfusion ( one required exchange transfusion two times). 11(45.83% n=24) neonates in the G6PD deficient
Study of Glucose -6-Phosphate Dehydrogenase deficiency in Neonatal Jaundice. On the other hand, out of 152 G6PD normal babies 12(5 were male & 7 were female) babies required exchange transfusion(7.89% n=152). Among these 12 babies, 7 were outborn(3 were preterm including one had early onset sepsis & one had sepsis with features of bilirubin encephalopathy,4 were term including two with associated sepsis & one with O-B incompatibility).Among 6 inborn babies, one was preterm & the rest were term. Out of 5 term babies, two had associated birth asphyxia, two had sepsis & one developed features of bilirubin encephalopathy along with sepsis. As a whole, two babies developed bilirubin encephalopathy.(Refer to Table- 
IV. Discussion
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme with considerable role in the metabolism of red blood cells (7) . The enzyme deficiency leads to impaired production of reduced glutathione and predisposes the red cells to damage by oxidative metabolites, causing acute or chronic hemolysis. Deficient neonates may be asymptomatic or manifest clinically as hyperbilirubinemia or even kernicterus. Screening for G6PD deficiency and recognition of prevalence of the enzyme deficiency in individual communities have got definite place in the investigation of cases with neonatal jaundice.
Prevalence among neonates with hyperbilirubinemia
In the present study, the frequency of G6PD deficiency among neonates with hyperbilirubinemia has been found to be 13.63% among mixed community (i.e. overall), 12.00% among Non-tribal newborns & 23.07% among Tribal newborn as found on enzymatic assay.
Sex Distribution
In our study, a total of 24 neonates were found to have G6PD deficiency. Frequency in males and females were 16.94% (20 out of 118 male babies) and 6.89% (4 out of 58 female babies) respectively. Here also, frequency was high among males. This male preponderance of G6PD deficiency is a well documented fact (10) . G6PD deficiency being an X-linked recessive disorder, the expression is greater in males as they have only one X-chromosome without ability to suppress expression of the defective gene. The heterozygous females having one defective gene and one normal gene may express as normal or mild deficiency and have the chance of escaping detection by usual screening tests or even enzyme assay.
Gestational period and Birth weight
Among those with birth weight of more than 2500 gm, 19 babies (13.76%; n=138) had G6PD deficiency. Out of 38 neonates with a birth weight of less than 2500 gm, 5 babies (13.16%; n=38) were found to have this enzyme deficiency. So, the prevalence of the enzyme deficiency among babies weighing more than 2.5 kg and those weighing less than 2.5 kg was similar (p >0.05).
Nineteen (13.57%; n=140) term babies & five (13.88%; n=36) preterm babies were G6PD deficient. This difference in frequency of G6PD deficiency among term and preterm babies was not statistically significant (p > 0.05).
Kuruvilla et al (11) studied 212 neonates with hyperbilirubinemia not caused by ABO and Rh incompatibility and found similar frequency of this enzyme deficiency among babies with different birth weights and gestation. Pattern of Jaundice:
V. Conclusion
G6PD deficiency is found to be a common cause of neonatal jaundice. It is more common in tribal population. It is one important cause of jaundice developing on day two onwards. The peak serum bilirubin level is more than 20mg/dl in majority of G6PD deficiency cases. All babies require phototherapy and in 45.83% of cases require exchange transfusion.
